The BRAIN Act (Bolstering Research And Innovation Now Act) is legislation designed to advance medical research and improve care for people with brain tumors, particularly glioblastoma. The bill establishes several key initiatives: it creates a searchable national database of brain tumor tissue samples and biospecimens to aid researchers, funds a Glioblastoma Therapeutics Network with $50 million annually through 2030 to test new treatments, and supports $10 million per year in cellular immunotherapy (including CAR-T) research. The legislation also authorizes a $10 million national public awareness campaign to educate patients, families, and healthcare providers about clinical trials and biomarker testing, with targeted outreach to underserved communities. Additionally, the bill funds pilot programs ($5 million annually) to develop better long-term care and monitoring approaches for brain tumor survivors and directs the FDA to issue guidance within one year to improve brain tumor patients' access to clinical trials. The legislation addresses a significant health challenge—brain tumors affect over one million Americans, with survival rates largely unchanged for 45 years—by boosting research funding and improving patient awareness and care coordination.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.